<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-10T15:54:45Z</responseDate>
  <request identifier="oai:figshare.com:article/33441169" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33441169</identifier>
        <datestamp>2026-09-18T02:57:33Z</datestamp>
        <setSpec>category_27199</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Supplementary Data and Code for: Immunogenicity and Safety of RSVPreF3 OA Coadministration versus Sequential Administration in Adults: A Systematic Review and Meta-Analysis</dc:title>
          <dc:creator>Shu Jiang (24713224)</dc:creator>
          <dc:subject>Preventative health care</dc:subject>
          <dc:subject>respiratory syncytial virus vaccine</dc:subject>
          <dc:subject>non-inferiority</dc:subject>
          <dc:subject>adults aged 50 years or older</dc:subject>
          <dc:description>&lt;p dir="ltr"&gt;This repository contains the dataset and supplementary materials for the systematic review and meta-analysis evaluating the immunogenicity and safety of respiratory syncytial virus (RSV) vaccine coadministration versus sequential administration in older adults. The study synthesized evidence from six randomized non-inferiority trials covering pneumococcal, COVID-19, herpes zoster, and influenza partner vaccines. The pooled analysis compares RSV neutralizing-antibody responses, partner-vaccine immunogenicity, and safety outcomes between same-day coadministration and sequential schedules to inform immunization practices.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-18T02:57:33Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.6084/m9.figshare.33441169.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Supplementary_Data_and_Code_for_Immunogenicity_and_Safety_of_RSVPreF3_OA_Coadministration_versus_Sequential_Administration_in_Adults_A_Systematic_Review_and_Meta-Analysis/33441169</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
